Matthew S Bogyo

Stanford University

$24,780,518

Attributed

$26,409,493

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$26,409,493 · 30

By mechanism

R01$17,693,495 · 10

R21$2,821,408 · 7

U54$2,514,170 · 8

T32$1,582,852 · 1

R33$1,402,327 · 1

R56$392,500 · 1

Top collaborators

Most similar at Stanford University

Same institution · by research overlap

Robert W Shafer$16,663,491
Marlene Rabinovitch$40,032,014
Jianghong Rao$21,022,312
Thomas C Merigan$8,107,440
Edward S. Mocarski$11,996,025

Others in their field

Top investigators on “Small Molecule”

David Heimbrook · Leidos Biomedical Research, Inc.$251,072,489
Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
Peter C Adamson · National Childhood Cancer Foundation$143,645,434
Mark S Klempner · Tufts Medical Center$128,021,180
Stuart L Schreiber · Harvard University (Medical School)$79,067,419
Edward A Dennis · University Of California, San Diego$73,030,813

Research focus

Small MoleculeCellsBaseDesignPeptide HydrolasesEnzymesLinkInhibitor/AntagonistLabelImageTissuesLibrariesMouse ModelFutureLeadProteinsPreventMonitorPathologyEventIn VivoAffectBiochemicalSignal Transduction

Grant awards (83)

Chemical probes for imaging and treatment of otitis media$496,496

R01 · FY2025 · EB · contact PI

Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseases$455,063

R01 · FY2025 · DK · contact PI

Protease sensor for rapid and sensitive detection of Borrelia infections$436,236

R21 · FY2025 · AI · contact PI

Molecular Pharmacology Training Program$426,360

T32 · FY2025 · GM

Molecular Pharmacology Training Program$439,487

T32 · FY2024 · GM

Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseases$438,309

R01 · FY2024 · DK · contact PI

Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseases$458,044

R01 · FY2023 · DK · contact PI

Molecular Pharmacology Training Program$424,428

T32 · FY2023 · GM

Dual orthogonal fluorescent protease sensors for image guided surgery$377,899

R01 · FY2023 · EB · contact PI

Covalent inhibitors of host cell entry by SARS-CoV-2 for treatment of COVID-19$236,100

R21 · FY2023 · AI · contact PI

Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseases$493,992

R01 · FY2022 · DK · contact PI

Covalent inhibitors of host cell entry by SARS-CoV-2 for treatment of COVID-19$196,750

R21 · FY2022 · AI · contact PI

Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseases$509,746

R01 · FY2021 · DK · contact PI

Parasite-specific proteasome inhibitors to combat multi-drug resistant malaria$454,467

R33 · FY2021 · AI · contact PI

Dual orthogonal fluorescent protease sensors for image guided surgery$365,662

R01 · FY2021 · EB · contact PI

Staphylococcus serine hydrolases as targets for therapeutic and imaging contrast agents$348,216

R01 · FY2021 · EB · contact PI

Generation of highly selective activity based probes using chemically modified phage$347,200

R01 · FY2021 · EB · contact PI

Development of Imaging Probes for Risk Assessment of Alzheimer's Disease using Phage Display$345,854

R01 · FY2021 · EB · contact PI

Molecular Pharmacology Training Program$292,577

T32 · FY2021 · GM

Parasite-specific proteasome inhibitors to combat multi-drug resistant malaria$462,817

R33 · FY2020 · AI · contact PI

Dual orthogonal fluorescent protease sensors for image guided surgery$377,028

R01 · FY2020 · EB · contact PI

Staphylococcus serine hydrolases as targets for therapeutic and imaging contrast agents$355,263

R01 · FY2020 · EB · contact PI

A rapid and inexpensive point of care diagnostic for SARS-CoV-2 infection$354,825

R01 · FY2020 · EB · contact PI

Generation of highly selective activity based probes using chemically modified phage$354,257

R01 · FY2020 · EB · contact PI

Parasite-specific proteasome inhibitors to combat multi-drug resistant malaria$485,043

R33 · FY2019 · AI · contact PI

Dual orthogonal fluorescent protease sensors for image guided surgery$396,420

R01 · FY2019 · EB · contact PI

Staphylococcus serine hydrolases as targets for therapeutic and imaging contrast agents$355,205

R01 · FY2019 · EB · contact PI

Generation of highly selective activity based probes using chemically modified phage$353,250

R01 · FY2019 · EB · contact PI

Generation of highly selective activity based probes using chemically modified phage$98,303

R01 · FY2019 · EB · contact PI

Staphylococcus serine hydrolases as targets for therapeutic and imaging contrast agents$355,148

R01 · FY2018 · EB · contact PI

Generation of highly selective activity based probes using chemically modified phage$353,250

R01 · FY2018 · EB · contact PI

Chemical probes for specific targeting of matrix metallo proteases$333,038

R01 · FY2018 · CA · contact PI

Parasite-specific proteasome inhibitors to combat multi-drug resistant malaria$215,097

R21 · FY2018 · AI · contact PI

Chemical probes for specific targeting of matrix metallo proteases$105,661

R01 · FY2018 · CA · contact PI

Chemical methods to study protein palmitoylation pathways$405,286

R01 · FY2017 · GM · contact PI

Development of non-antibiotic therapeutics for Clostridium difficile infection (CDI)$392,500

R56 · FY2017 · AI · contact PI

Chemical probes for specific targeting of matrix metallo proteases$333,038

R01 · FY2017 · CA · contact PI

Parasite-specific proteasome inhibitors to combat multi-drug resistant malaria$231,625

R21 · FY2017 · AI · contact PI

Chemical probes for specific targeting of matrix metallo proteases$65,562

R01 · FY2017 · CA · contact PI

Chemical probes for specific targeting of matrix metallo proteases$333,038

R01 · FY2016 · CA · contact PI

Chemical methods to study protein palmitoylation pathways$304,950

R01 · FY2016 · GM · contact PI

Equipment supplement for Chemical methods to study protein palmitoylation pathways$187,738

R01 · FY2016 · GM · contact PI

Chemical methods to study protein palmitoylation pathways$83,614

R01 · FY2016 · GM · contact PI

Chemical probes for specific targeting of matrix metallo proteases$333,038

R01 · FY2015 · CA · contact PI

Chemical methods to study protein palmitoylation pathways$304,950

R01 · FY2015 · GM · contact PI

Multiplexed in vivo drug screening: Inhibitors of metastatic seeding$175,167

R21 · FY2015 · CA

Cathepsin S-targeted probes for optical and PET imaging of lung fibrosis$470,571

R01 · FY2014 · HL · contact PI

Chemical probes for specific targeting of matrix metallo proteases$333,038

R01 · FY2014 · CA · contact PI

Chemical methods to study protein palmitoylation pathways$304,950

R01 · FY2014 · GM · contact PI

Multiplexed in vivo drug screening: Inhibitors of metastatic seeding$209,745

R21 · FY2014 · CA

Small Molecule Imaging of Protease Activity$434,134

R01 · FY2013 · EB · contact PI

Cathepsin S-targeted probes for optical and PET imaging of lung fibrosis$374,524

R01 · FY2013 · HL · contact PI

Chemically Mapping Malarial Rupture Proteases$370,332

R01 · FY2013 · AI · contact PI

Cathepsin S-targeted probes for optical and PET imaging of lung fibrosis$79,618

R01 · FY2013 · HL · contact PI

Small Molecule Imaging of Protease Activity$458,267

R01 · FY2012 · EB · contact PI

Chemically Mapping Malarial Rupture Proteases$393,897

R01 · FY2012 · AI · contact PI

Cathepsin S-targeted probes for optical and PET imaging of lung fibrosis$393,357

R01 · FY2012 · HL · contact PI

Chemical Methods for Ferrous Iron Targeted Drug Delivery$235,063

R21 · FY2012 · AI

Chemically Mapping Malarial Rupture Proteases$393,824

R01 · FY2011 · AI · contact PI

Small Molecule Imaging of Protease Activity$350,180

R01 · FY2011 · EB · contact PI

Chemical Methods for Ferrous Iron Targeted Drug Delivery$207,625

R21 · FY2011 · AI

Chemical characterization of SUMO specific proteases in Plasmodium falciparum$198,000

R21 · FY2011 · AI · contact PI

Small Molecule Imaging of Protease Activity$35,292

R01 · FY2011 · EB · contact PI

Chemically Mapping Malarial Rupture Proteases$397,734

R01 · FY2010 · AI · contact PI

Small Molecule Imaging of Protease Activity$364,074

R01 · FY2010 · EB · contact PI

Chemical characterization of SUMO specific proteases in Plasmodium falciparum$240,000

R21 · FY2010 · AI · contact PI

Development of small molecule probes of matrix metallo protease function$240,000

R21 · FY2010 · EB · contact PI

Chemically Mapping Malarial Rupture Proteases$401,589

R01 · FY2009 · AI · contact PI

CORE 1 TRP1: ACTIVITY-BASED PROTEASE PROFILING (ABPP)$355,670

U54 · FY2008 · RR · contact PI

Small Molecule Imaging of Cysteine Protease Activity$331,496

R01 · FY2008 · EB · contact PI

CORE 3A: INFRASTRUCTURE CHEMISTRY$286,016

U54 · FY2008 · RR · contact PI

CORE 1 TRP1: ACTIVITY-BASED PROTEASE PROFILING (ABPP)$340,830

U54 · FY2007 · RR · contact PI

Small Molecule Imaging of Cysteine Protease Activity$333,052

R01 · FY2007 · EB · contact PI

CORE 3A: INFRASTRUCTURE CHEMISTRY$274,110

U54 · FY2007 · RR · contact PI

CORE 1 TRP1: ACTIVITY-BASED PROTEASE PROFILING (ABPP)$367,371

U54 · FY2006 · RR · contact PI

Small Molecule Imaging of Cysteine Protease Activity$342,989

R01 · FY2006 · EB · contact PI

CORE 3A: INFRASTRUCTURE CHEMISTRY$295,457

U54 · FY2006 · RR · contact PI

IDENTIFICATION OF PROTEIN NUCLEOPHILES USING SMALL ELECTROPHILIC MOLECULES$24

P41 · FY2006 · RR · contact PI

Small Molecule Imaging of Cysteine Protease Activity$351,234

R01 · FY2005 · EB

CORE 1 TRP1: ACTIVITY-BASED PROTEASE PROFILING (ABPP)(RM$329,620

U54 · FY2005 · RR

CORE 3A: INFRASTRUCTURE CHEMISTRY$265,096

U54 · FY2005 · RR

IDENTIFICATION OF PROTEIN NUCLEOPHILES USING SMALL ELECTROPHILIC MOLECULES$24

P41 · FY2005 · RR

IDENTIFICATION OF PROTEIN NUCLEOPHILES USING SMALL ELECTROPHILIC MOLECULES$2,693

P41 · FY2004 · RR